ES2188826T3 - Sintesis en fase solida de oligonucleotidos. - Google Patents
Sintesis en fase solida de oligonucleotidos.Info
- Publication number
- ES2188826T3 ES2188826T3 ES97111426T ES97111426T ES2188826T3 ES 2188826 T3 ES2188826 T3 ES 2188826T3 ES 97111426 T ES97111426 T ES 97111426T ES 97111426 T ES97111426 T ES 97111426T ES 2188826 T3 ES2188826 T3 ES 2188826T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- groups
- alkoxy
- protected
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 2
- 238000010532 solid phase synthesis reaction Methods 0.000 title abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002773 nucleotide Substances 0.000 abstract 3
- 125000003729 nucleotide group Chemical group 0.000 abstract 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 238000010511 deprotection reaction Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000000269 nucleophilic effect Effects 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000005336 allyloxy group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000371 nucleobase group Chemical group 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- -1 p-nitrophenylethyl Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000006245 phosphate protecting group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19627898A DE19627898A1 (de) | 1996-07-11 | 1996-07-11 | Festphasensynthese von Oligonucleotiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2188826T3 true ES2188826T3 (es) | 2003-07-01 |
Family
ID=7799510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97111426T Expired - Lifetime ES2188826T3 (es) | 1996-07-11 | 1997-07-07 | Sintesis en fase solida de oligonucleotidos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5936077A (https=) |
| EP (1) | EP0818460B1 (https=) |
| JP (1) | JP4435878B2 (https=) |
| AT (1) | ATE231162T1 (https=) |
| AU (1) | AU716391B2 (https=) |
| CA (1) | CA2210031C (https=) |
| DE (2) | DE19627898A1 (https=) |
| DK (1) | DK0818460T3 (https=) |
| ES (1) | ES2188826T3 (https=) |
| NO (1) | NO317853B1 (https=) |
| PT (1) | PT818460E (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274725B1 (en) * | 1998-06-02 | 2001-08-14 | Isis Pharmaceuticals, Inc. | Activators for oligonucleotide synthesis |
| AU4965499A (en) | 1998-07-09 | 2000-02-01 | Biocept, Inc. | Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| DE19842164B4 (de) * | 1998-09-15 | 2004-06-03 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Verfahren zur Qualitätskontrolle beim Aufbau von Oligomerrastern |
| US6175001B1 (en) * | 1998-10-16 | 2001-01-16 | The Scripps Research Institute | Functionalized pyrimidine nucleosides and nucleotides and DNA's incorporating same |
| US6465628B1 (en) | 1999-02-04 | 2002-10-15 | Isis Pharmaceuticals, Inc. | Process for the synthesis of oligomeric compounds |
| US6887990B1 (en) | 1999-02-05 | 2005-05-03 | Amersham Biosciences Corp | Method for deprotecting oligonucleotides |
| ATE312841T1 (de) * | 2001-03-08 | 2005-12-15 | Applera Corp | Verfahren zum entschützen von oligonukleotide |
| WO2006025154A1 (ja) * | 2004-08-30 | 2006-03-09 | Gifu University | 修飾オリゴヌクレオチド |
| DE102006016473A1 (de) * | 2005-12-08 | 2007-06-14 | Continental Teves Ag & Co. Ohg | Druckregelventil |
| CA2721969C (en) * | 2008-04-24 | 2016-06-07 | Girindus America, Inc. | Process for the manufacture of oligonucleotides |
| US9708360B2 (en) | 2013-09-30 | 2017-07-18 | Geron Corporation | Phosphorodiamidate backbone linkage for oligonucleotides |
| WO2017066782A1 (en) * | 2015-10-16 | 2017-04-20 | Modernatx, Inc. | Hydrophobic mrna cap analogs |
| WO2017066797A1 (en) | 2015-10-16 | 2017-04-20 | Modernatx, Inc. | Trinucleotide mrna cap analogs |
| SI3362461T1 (sl) | 2015-10-16 | 2022-05-31 | Modernatx, Inc. | Analogi kape MRNA z modificirano fosfatno povezavo |
| CA3033867A1 (en) | 2016-08-17 | 2018-02-22 | Solstice Biologics, Ltd. | Polynucleotide constructs |
| US11597744B2 (en) | 2017-06-30 | 2023-03-07 | Sirius Therapeutics, Inc. | Chiral phosphoramidite auxiliaries and methods of their use |
| KR20190090301A (ko) | 2018-01-24 | 2019-08-01 | 에스티팜 주식회사 | 신규한 뉴클레오사이드 또는 뉴클레오타이드 유도체 및 이들의 용도 |
| CN115772201B (zh) * | 2021-09-08 | 2024-11-26 | 苏州金唯智生物科技有限公司 | 一种固相合成rna的后处理方法及其应用 |
| CN117362370B (zh) * | 2023-12-07 | 2024-03-05 | 北京百力格生物科技有限公司 | 核苷亚磷酰胺单体及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR930016437A (ko) * | 1992-01-22 | 1993-08-26 | 귀틀라인, 슈미트 | 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도 |
| US5623068A (en) * | 1994-03-07 | 1997-04-22 | Beckman Instruments, Inc. | Synthesis of DNA using substituted phenylacetyl-protected nucleotides |
-
1996
- 1996-07-11 DE DE19627898A patent/DE19627898A1/de not_active Withdrawn
-
1997
- 1997-07-07 PT PT97111426T patent/PT818460E/pt unknown
- 1997-07-07 DK DK97111426T patent/DK0818460T3/da active
- 1997-07-07 ES ES97111426T patent/ES2188826T3/es not_active Expired - Lifetime
- 1997-07-07 DE DE59709128T patent/DE59709128D1/de not_active Expired - Lifetime
- 1997-07-07 AT AT97111426T patent/ATE231162T1/de active
- 1997-07-07 EP EP97111426A patent/EP0818460B1/de not_active Expired - Lifetime
- 1997-07-09 AU AU28552/97A patent/AU716391B2/en not_active Ceased
- 1997-07-10 JP JP18514297A patent/JP4435878B2/ja not_active Expired - Fee Related
- 1997-07-10 CA CA002210031A patent/CA2210031C/en not_active Expired - Fee Related
- 1997-07-10 NO NO19973217A patent/NO317853B1/no not_active IP Right Cessation
- 1997-07-11 US US08/893,614 patent/US5936077A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4435878B2 (ja) | 2010-03-24 |
| DE19627898A1 (de) | 1998-01-15 |
| ATE231162T1 (de) | 2003-02-15 |
| CA2210031A1 (en) | 1998-01-11 |
| AU2855297A (en) | 1998-01-22 |
| NO317853B1 (no) | 2004-12-20 |
| EP0818460B1 (de) | 2003-01-15 |
| NO973217L (no) | 1998-01-12 |
| CA2210031C (en) | 2008-04-22 |
| EP0818460A3 (de) | 1999-02-24 |
| AU716391B2 (en) | 2000-02-24 |
| JPH1072486A (ja) | 1998-03-17 |
| US5936077A (en) | 1999-08-10 |
| DK0818460T3 (da) | 2003-05-05 |
| DE59709128D1 (de) | 2003-02-20 |
| NO973217D0 (no) | 1997-07-10 |
| PT818460E (pt) | 2003-06-30 |
| EP0818460A2 (de) | 1998-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2188826T3 (es) | Sintesis en fase solida de oligonucleotidos. | |
| RU2221798C2 (ru) | Имидазонафтиридины, фармацевтическая композиция на их основе, способ стимуляции биосинтеза цитокина и промежуточные вещества | |
| CA2087818A1 (en) | Oligonucleotide analogs, their preparation and use | |
| WO2002097134A2 (en) | Modified peptide nucleic acid | |
| EP0699208A1 (en) | Novel peptide nucleic acids | |
| JPH1072486A5 (https=) | ||
| ATE339434T1 (de) | Basenanaloge | |
| Wipf et al. | Synthesis of chemoreversible prodrugs of ara-C with variable time-release profiles. Biological evaluation of their apoptotic activity | |
| JP2004500403A (ja) | オリゴヌクレオチドおよびポリヌクレオチド合成のための反応性単量体、修飾されたオリゴヌクレオチドおよびポリヌクレオチド、ならびにそれらの製造方法 | |
| HU226867B1 (en) | Method for producing polymers having nucleo-bases as side-groups | |
| Zubin et al. | Oligonucleotides containing 2′-O-[2-(2, 3-dihydroxypropyl) amino-2-oxoethyl] uridine as suitable precursors of 2′-aldehyde oligonucleotides for chemoselective ligation | |
| Kutterer et al. | Synthesis and hybridization studies of urea and carbamate linked thymidine dimers incorporated into oligodeoxynucleosides | |
| Dioubankova et al. | Phosphoramidites and solid supports based on N-substituted 2, 4-dihydroxybutyramides: universal reagents for synthesis of modified oligonucleotides | |
| Baraniak et al. | Synthesis of nucleoside–amino acid conjugates containing boranephosphate, boranephosphorothioate and boranephosphoramidate linkages | |
| Laurent et al. | A new route to oligodeoxynucleoside phosphoramidates (P NH2) | |
| Pitsch | Towards a total synthesis of aminoacylated t-RNAs | |
| CA2577339C (en) | Artificial rna modified at its 2' hydroxyl group | |
| Yu et al. | Synthesis and characterization of a tetranucleotide analogue containing alternating phosphonate-amide backbone linkages | |
| Egger et al. | Bicyclo [3.2. 1] amide-DNA: Synthesis and base-pairing properties | |
| US6872809B2 (en) | Nucleoside derivatives | |
| Nagatsugi et al. | Design and synthesis of the novel cross-linking reagents triggered by the triple helix formation | |
| Adams et al. | Incorporation of 6-thioinosine into oligoribonucleotides | |
| Nelson | Synthesis and oligomerization of y, 4-Diamino-2-oxo-1 (2H)-pyrimidinepentanoic acid | |
| KR20150131045A (ko) | 아미노산 곁사슬을 포함하는 합성 중합체 | |
| WO2003059925A1 (en) | Calix[4]arene-nucleoside and calix[4]arene-oligonucleotide hybrids |